United States Vaccine Adjuvants Industry 2018 Market Research Report

Published: Jan, 2018 | Pages: 99 | Publisher: QYResearch
Industry: Medical Devices | Report Format: Electronic (PDF)

In this report, the United States Vaccine Adjuvants market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Vaccine Adjuvants in these regions, from 2013 to 2025 (forecast).

United States Vaccine Adjuvants market competition by top manufacturers/players, with Vaccine Adjuvants sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Brenntag Biosector
    Seppic
    CSL Limited
    Agenus
    Novavax
    Invivogen
    SPI Pharma
    Avanti Polar Lipids
    MPV Technologies
    OZ Biosciences

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Oral
    Subcutaneous
    Intramuscular
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Human Vaccine Adjuvants
    Research Applications
    Commercial Applications

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

United States Vaccine Adjuvants Market Report 2018
1 Vaccine Adjuvants Overview
    1.1 Product Overview and Scope of Vaccine Adjuvants
    1.2 Classification of Vaccine Adjuvants by Product Category
        1.2.1 United States Vaccine Adjuvants Market Size (Sales Volume) Comparison by Type (2013-2025)
        1.2.2 United States Vaccine Adjuvants Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
        1.2.3 Oral
        1.2.4 Subcutaneous
        1.2.5 Intramuscular
        1.2.6 Others
    1.3 United States Vaccine Adjuvants Market by Application/End Users
        1.3.1 United States Vaccine Adjuvants Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
        1.3.2 Human Vaccine Adjuvants
        1.3.3 Research Applications
        1.3.4 Commercial Applications
    1.4 United States Vaccine Adjuvants Market by Region
        1.4.1 United States Vaccine Adjuvants Market Size (Value) Comparison by Region (2013-2025)
        1.4.2 The West Vaccine Adjuvants Status and Prospect (2013-2025)
        1.4.3 Southwest Vaccine Adjuvants Status and Prospect (2013-2025)
        1.4.4 The Middle Atlantic Vaccine Adjuvants Status and Prospect (2013-2025)
        1.4.5 New England Vaccine Adjuvants Status and Prospect (2013-2025)
        1.4.6 The South Vaccine Adjuvants Status and Prospect (2013-2025)
        1.4.7 The Midwest Vaccine Adjuvants Status and Prospect (2013-2025)
    1.5 United States Market Size (Value and Volume) of Vaccine Adjuvants (2013-2025)
        1.5.1 United States Vaccine Adjuvants Sales and Growth Rate (2013-2025)
        1.5.2 United States Vaccine Adjuvants Revenue and Growth Rate (2013-2025)

2 United States Vaccine Adjuvants Market Competition by Players/Suppliers
    2.1 United States Vaccine Adjuvants Sales and Market Share of Key Players/Suppliers (2013-2018)
    2.2 United States Vaccine Adjuvants Revenue and Share by Players/Suppliers (2013-2018)
    2.3 United States Vaccine Adjuvants Average Price by Players/Suppliers (2013-2018)
    2.4 United States Vaccine Adjuvants Market Competitive Situation and Trends
        2.4.1 United States Vaccine Adjuvants Market Concentration Rate
        2.4.2 United States Vaccine Adjuvants Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Vaccine Adjuvants Manufacturing Base Distribution, Sales Area, Product Type

3 United States Vaccine Adjuvants Sales (Volume) and Revenue (Value) by Region (2013-2018)
    3.1 United States Vaccine Adjuvants Sales and Market Share by Region (2013-2018)
    3.2 United States Vaccine Adjuvants Revenue and Market Share by Region (2013-2018)
    3.3 United States Vaccine Adjuvants Price by Region (2013-2018)

4 United States Vaccine Adjuvants Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
    4.1 United States Vaccine Adjuvants Sales and Market Share by Type (Product Category) (2013-2018)
    4.2 United States Vaccine Adjuvants Revenue and Market Share by Type (2013-2018)
    4.3 United States Vaccine Adjuvants Price by Type (2013-2018)
    4.4 United States Vaccine Adjuvants Sales Growth Rate by Type (2013-2018)

5 United States Vaccine Adjuvants Sales (Volume) by Application (2013-2018)
    5.1 United States Vaccine Adjuvants Sales and Market Share by Application (2013-2018)
    5.2 United States Vaccine Adjuvants Sales Growth Rate by Application (2013-2018)
    5.3 Market Drivers and Opportunities

6  United States Vaccine Adjuvants Players/Suppliers Profiles and Sales Data
    6.1 Brenntag Biosector
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Vaccine Adjuvants Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2013-2018)
        6.1.4 Main Business/Business Overview
    6.2 Seppic
        6.2.2 Vaccine Adjuvants Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Seppic Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2013-2018)
        6.2.4 Main Business/Business Overview
    6.3 CSL Limited
        6.3.2 Vaccine Adjuvants Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 CSL Limited Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2013-2018)
        6.3.4 Main Business/Business Overview
    6.4 Agenus
        6.4.2 Vaccine Adjuvants Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Agenus Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2013-2018)
        6.4.4 Main Business/Business Overview
    6.5 Novavax
        6.5.2 Vaccine Adjuvants Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Novavax Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2013-2018)
        6.5.4 Main Business/Business Overview
    6.6 Invivogen
        6.6.2 Vaccine Adjuvants Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Invivogen Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2013-2018)
        6.6.4 Main Business/Business Overview
    6.7 SPI Pharma
        6.7.2 Vaccine Adjuvants Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 SPI Pharma Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2013-2018)
        6.7.4 Main Business/Business Overview
    6.8 Avanti Polar Lipids
        6.8.2 Vaccine Adjuvants Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Avanti Polar Lipids Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2013-2018)
        6.8.4 Main Business/Business Overview
    6.9 MPV Technologies
        6.9.2 Vaccine Adjuvants Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 MPV Technologies Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2013-2018)
        6.9.4 Main Business/Business Overview
    6.10 OZ Biosciences
        6.10.2 Vaccine Adjuvants Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 OZ Biosciences Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2013-2018)
        6.10.4 Main Business/Business Overview

7 Vaccine Adjuvants Manufacturing Cost Analysis
    7.1 Vaccine Adjuvants Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Vaccine Adjuvants

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Vaccine Adjuvants Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Vaccine Adjuvants Major Manufacturers in 2017
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Vaccine Adjuvants Market Size (Value and Volume) Forecast (2018-2025)
    11.1 United States Vaccine Adjuvants Sales Volume, Revenue Forecast (2018-2025)
    11.2 United States Vaccine Adjuvants Sales Volume Forecast by Type (2018-2025)
    11.3 United States Vaccine Adjuvants Sales Volume Forecast by Application (2018-2025)
    11.4 United States Vaccine Adjuvants Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer

List of Tables and Figures

    Figure Product Picture of Vaccine Adjuvants
    Figure United States Vaccine Adjuvants Market Size (K Units) by Type (2013-2025)
    Figure United States Vaccine Adjuvants Sales Volume Market Share by Type (Product Category) in 2017
    Figure Oral Product Picture
    Figure Subcutaneous Product Picture
    Figure Intramuscular Product Picture
    Figure Others Product Picture
    Figure United States Vaccine Adjuvants Market Size (K Units) by Application (2013-2025)
    Figure United States Sales Market Share of Vaccine Adjuvants by Application in 2017
    Figure Human Vaccine Adjuvants Examples
    Table Key Downstream Customer in Human Vaccine Adjuvants
    Figure Research Applications Examples
    Table Key Downstream Customer in Research Applications
    Figure Commercial Applications Examples
    Table Key Downstream Customer in Commercial Applications
    Figure United States Vaccine Adjuvants Market Size (Million USD) by Region (2013-2025)
    Figure The West Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Southwest Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2013-2025)
    Figure The Middle Atlantic Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2013-2025)
    Figure New England Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2013-2025)
    Figure The South of US Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2013-2025)
    Figure The Midwest Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2013-2025)
    Figure United States Vaccine Adjuvants Sales (K Units) and Growth Rate (2013-2025)
    Figure United States Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2013-2025)
    Figure United States Vaccine Adjuvants Market Major Players Product Sales Volume (K Units) (2013-2018)
    Table United States Vaccine Adjuvants Sales (K Units) of Key Players/Suppliers (2013-2018)
    Table United States Vaccine Adjuvants Sales Share by Players/Suppliers (2013-2018)
    Figure 2017 United States Vaccine Adjuvants Sales Share by Players/Suppliers
    Figure 2017 United States Vaccine Adjuvants Sales Share by Players/Suppliers
    Figure United States Vaccine Adjuvants Market Major Players Product Revenue (Million USD) (2013-2018)
    Table United States Vaccine Adjuvants Revenue (Million USD) by Players/Suppliers (2013-2018)
    Table United States Vaccine Adjuvants Revenue Share by Players/Suppliers (2013-2018)
    Figure 2017 United States Vaccine Adjuvants Revenue Share by Players/Suppliers
    Figure 2017 United States Vaccine Adjuvants Revenue Share by Players/Suppliers
    Table United States Market Vaccine Adjuvants Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
    Figure United States Market Vaccine Adjuvants Average Price (USD/Unit) of Key Players/Suppliers in 2017
    Figure United States Vaccine Adjuvants Market Share of Top 3 Players/Suppliers
    Figure United States Vaccine Adjuvants Market Share of Top 5 Players/Suppliers
    Table United States Players/Suppliers Vaccine Adjuvants Manufacturing Base Distribution and Sales Area
    Table United States Players/Suppliers Vaccine Adjuvants Product Category
    Table United States Vaccine Adjuvants Sales (K Units) by Region (2013-2018)
    Table United States Vaccine Adjuvants Sales Share by Region (2013-2018)
    Figure United States Vaccine Adjuvants Sales Share by Region (2013-2018)
    Figure United States Vaccine Adjuvants Sales Market Share by Region in 2017
    Table United States Vaccine Adjuvants Revenue (Million USD) and Market Share by Region (2013-2018)
    Table United States Vaccine Adjuvants Revenue Share by Region (2013-2018)
    Figure United States Vaccine Adjuvants Revenue Market Share by Region (2013-2018)
    Figure United States Vaccine Adjuvants Revenue Market Share by Region in 2017
    Table United States Vaccine Adjuvants Price (USD/Unit) by Region (2013-2018)
    Table United States Vaccine Adjuvants Sales (K Units) by Type (2013-2018)
    Table United States Vaccine Adjuvants Sales Share by Type (2013-2018)
    Figure United States Vaccine Adjuvants Sales Share by Type (2013-2018)
    Figure United States Vaccine Adjuvants Sales Market Share by Type in 2017
    Table United States Vaccine Adjuvants Revenue  (Million USD) and Market Share by Type (2013-2018)
    Table United States Vaccine Adjuvants Revenue Share by Type (2013-2018)
    Figure Revenue Market Share of Vaccine Adjuvants by Type (2013-2018)
    Figure Revenue Market Share of Vaccine Adjuvants by Type in 2017
    Table United States Vaccine Adjuvants Price (USD/Unit) by Types (2013-2018)
    Figure United States Vaccine Adjuvants Sales Growth Rate by Type (2013-2018)
    Table United States Vaccine Adjuvants Sales (K Units) by Application (2013-2018)
    Table United States Vaccine Adjuvants Sales Market Share by Application (2013-2018)
    Figure United States Vaccine Adjuvants Sales Market Share by Application (2013-2018)
    Figure United States Vaccine Adjuvants Sales Market Share by Application in 2017
    Table United States Vaccine Adjuvants Sales Growth Rate by Application (2013-2018)
    Figure United States Vaccine Adjuvants Sales Growth Rate by Application (2013-2018)
    Table Brenntag Biosector Basic Information List
    Table Brenntag Biosector Vaccine Adjuvants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Brenntag Biosector Vaccine Adjuvants Sales Growth Rate (2013-2018)
    Figure Brenntag Biosector Vaccine Adjuvants Sales Market Share in United States (2013-2018)
    Figure Brenntag Biosector Vaccine Adjuvants Revenue Market Share in United States (2013-2018)
    Table Seppic Basic Information List
    Table Seppic Vaccine Adjuvants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Seppic Vaccine Adjuvants Sales Growth Rate (2013-2018)
    Figure Seppic Vaccine Adjuvants Sales Market Share in United States (2013-2018)
    Figure Seppic Vaccine Adjuvants Revenue Market Share in United States (2013-2018)
    Table CSL Limited Basic Information List
    Table CSL Limited Vaccine Adjuvants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure CSL Limited Vaccine Adjuvants Sales Growth Rate (2013-2018)
    Figure CSL Limited Vaccine Adjuvants Sales Market Share in United States (2013-2018)
    Figure CSL Limited Vaccine Adjuvants Revenue Market Share in United States (2013-2018)
    Table Agenus Basic Information List
    Table Agenus Vaccine Adjuvants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Agenus Vaccine Adjuvants Sales Growth Rate (2013-2018)
    Figure Agenus Vaccine Adjuvants Sales Market Share in United States (2013-2018)
    Figure Agenus Vaccine Adjuvants Revenue Market Share in United States (2013-2018)
    Table Novavax Basic Information List
    Table Novavax Vaccine Adjuvants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Novavax Vaccine Adjuvants Sales Growth Rate (2013-2018)
    Figure Novavax Vaccine Adjuvants Sales Market Share in United States (2013-2018)
    Figure Novavax Vaccine Adjuvants Revenue Market Share in United States (2013-2018)
    Table Invivogen Basic Information List
    Table Invivogen Vaccine Adjuvants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Invivogen Vaccine Adjuvants Sales Growth Rate (2013-2018)
    Figure Invivogen Vaccine Adjuvants Sales Market Share in United States (2013-2018)
    Figure Invivogen Vaccine Adjuvants Revenue Market Share in United States (2013-2018)
    Table SPI Pharma Basic Information List
    Table SPI Pharma Vaccine Adjuvants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure SPI Pharma Vaccine Adjuvants Sales Growth Rate (2013-2018)
    Figure SPI Pharma Vaccine Adjuvants Sales Market Share in United States (2013-2018)
    Figure SPI Pharma Vaccine Adjuvants Revenue Market Share in United States (2013-2018)
    Table Avanti Polar Lipids Basic Information List
    Table Avanti Polar Lipids Vaccine Adjuvants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Avanti Polar Lipids Vaccine Adjuvants Sales Growth Rate (2013-2018)
    Figure Avanti Polar Lipids Vaccine Adjuvants Sales Market Share in United States (2013-2018)
    Figure Avanti Polar Lipids Vaccine Adjuvants Revenue Market Share in United States (2013-2018)
    Table MPV Technologies Basic Information List
    Table MPV Technologies Vaccine Adjuvants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure MPV Technologies Vaccine Adjuvants Sales Growth Rate (2013-2018)
    Figure MPV Technologies Vaccine Adjuvants Sales Market Share in United States (2013-2018)
    Figure MPV Technologies Vaccine Adjuvants Revenue Market Share in United States (2013-2018)
    Table OZ Biosciences Basic Information List
    Table OZ Biosciences Vaccine Adjuvants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure OZ Biosciences Vaccine Adjuvants Sales Growth Rate (2013-2018)
    Figure OZ Biosciences Vaccine Adjuvants Sales Market Share in United States (2013-2018)
    Figure OZ Biosciences Vaccine Adjuvants Revenue Market Share in United States (2013-2018)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Vaccine Adjuvants
    Figure Manufacturing Process Analysis of Vaccine Adjuvants
    Figure Vaccine Adjuvants Industrial Chain Analysis
    Table Raw Materials Sources of Vaccine Adjuvants Major Players/Suppliers in 2017
    Table Major Buyers of Vaccine Adjuvants
    Table Distributors/Traders List
    Figure United States Vaccine Adjuvants Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure United States Vaccine Adjuvants Revenue  (Million USD) and Growth Rate Forecast (2018-2025)
    Figure United States Vaccine Adjuvants Price (USD/Unit) Trend Forecast (2018-2025)
    Table United States Vaccine Adjuvants Sales Volume (K Units) Forecast by Type (2018-2025)
    Figure United States Vaccine Adjuvants Sales Volume (K Units) Forecast by Type (2018-2025)
    Figure United States Vaccine Adjuvants Sales Volume (K Units) Forecast by Type in 2025
    Table United States Vaccine Adjuvants Sales Volume (K Units) Forecast by Application (2018-2025)
    Figure United States Vaccine Adjuvants Sales Volume (K Units) Forecast by Application (2018-2025)
    Figure United States Vaccine Adjuvants Sales Volume (K Units) Forecast by Application in 2025
    Table United States Vaccine Adjuvants Sales Volume (K Units) Forecast by Region (2018-2025)
    Table United States Vaccine Adjuvants Sales Volume Share Forecast by Region (2018-2025)
    Figure United States Vaccine Adjuvants Sales Volume Share Forecast by Region (2018-2025)
    Figure United States Vaccine Adjuvants Sales Volume Share Forecast by Region in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

To request a free sample copy of this report, please complete the form below.

Interested in this report? Get your FREE sample now! Get a Free Sample

Did you know?

Our library has over 100000 reports on 1000s of topics

Over 100+ Fortune 500 companies rely on us

90,000+ people come to us for insights every month

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.